news

Pfizer Quarterly Sales Up 58%

In the II quarter of 2010, the net profit of the American pharmaceutical company grew by 9% and amounted to 2.47 billion US dollars against 2.26 billion dollars a year earlier. At the same time, earnings per share decreased by 9% to $0.31 compared to $0.34 in the second quarter of 2009.

Pfizer Quarterly Sales Up 58% Read More »

FDA Approves Combination Antihypertensive Tribenzor™

On July 26, the Japanese company Daiichi Sankyo Co. Ltd.” announced that the US Food and Drug Administration (FDA) has approved its combination drug Tribenzor™ (olmesartan + amlodipine + hydrochlorothiazide) for the treatment of hypertension in patients whose blood pressure is unresponsive to other combination antihypertensive drugs. means. Daiichi Sankyo notes that Tribenzor simplifies dosing regimens and also

FDA Approves Combination Antihypertensive Tribenzor™ Read More »